Boundless Bio Inc. (BOLD)
NASDAQ:BOLD
US Market
Holding BOLD?
Track your performance easily

Boundless Bio Inc. (BOLD) Income Statement

23 Followers

Boundless Bio Inc. Income Statement

Last quarter (Q3 2024), Boundless Bio Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Boundless Bio Inc.'s net income was $-16.51M. See Boundless Bio Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
----
Cost of Revenue
----
Gross Profit
----
Operating Expense
$ 66.83M$ 54.80M$ 46.47M$ 25.31M
Operating Income
$ -66.83M$ -54.80M$ -46.47M$ -25.31M
Net Non Operating Interest Income Expense
$ 7.88M$ 5.28M$ 668.00K$ 96.00K
Other Income Expense
$ -145.00K$ -80.00K$ 100.00K-
Pretax Income
$ -58.80M$ -49.43M$ -45.90M$ -25.21M
Tax Provision
----
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -58.80M$ -49.43M$ -45.90M$ -25.21M
Basic EPS
$ -1.88$ -40.65$ -41.80$ -1.50
Diluted EPS
$ -1.88$ -40.65$ -41.80$ -1.50
Basic Average Shares
$ 2.55M$ 1.22M$ 1.10M$ 16.78M
Diluted Average Shares
$ 2.55M$ 1.22M$ 1.10M$ 16.78M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 66.83M$ 54.80M$ 46.47M$ 25.31M
Net Income From Continuing And Discontinued Operation
$ -58.80M$ -49.43M$ -45.90M$ -25.21M
Normalized Income
$ -33.15M---
Interest Expense
----
EBIT
$ -33.48M---
EBITDA
$ -32.96M---
Currency in USD

Boundless Bio Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis